The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.
Abstract
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436–1444.FridkinSK]]HagemanJC]]MorrisonM&etal;Methicillin-resistant Staphylococcus aureus disease in three communities.N Engl J Med20053521436-14442. Gorwitz RJ. A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J 2008;27:1–7.GorwitzRJA review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.Pediatr Infect Dis J2008271-73. Deurenberg RH, Vink C, Kalenic S, et al. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2007;13:222–235.DeurenbergRH]]VinkC]]KalenicS&etal;The molecular evolution of methicillin-resistant Staphylococcus aureus.Clin Microbiol Infect200713222-2354. Le J, Lieberman JM. Management of community-associated methicillin-resistant Staphylococcus aureus infections in children. Pharmacotherapy 2006;26:1758–1770.LeJ]]LiebermanJMManagement of community-associated methicillin-resistant Staphylococcus aureus infections in children.Pharmacotherapy2006261758-17705. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666–674.MoranGJ]]KrishnadasanA]]GorwitzRJ&etal;Methicillin-resistant S. aureus infections among patients in the emergency department.N Engl J Med2006355666-6746. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005;40:1785–1791.KaplanSL]]HultenKG]]GonzalezBE&etal;Three-year surveillance of community-acquired Staphylococcus aureus infections in children.Clin Infect Dis2005401785-17917. Furuya EY, Cook HA, Lee MH, et al. Community-associated methicillin-resistant Staphlococcus aureus prevalence: how common is it? A methodological comparison of prevalence ascertainment. Am J Infect Control 2007;35:359–366.FuruyaEY]]CookHA]]LeeMH&etal;Community-associated methicillin-resistant Staphlococcus aureus prevalence: how common is it? A methodological comparison of prevalence ascertainment.Am J Infect Control200735359-3668. Tejeda-Ramirez E, Behani M, Leggiadro RJ. Community-associated methicillin-resistant staphylococcal infection in an inner city hospital pediatric inpatient population. South Med J 2009;102:135–138.Tejeda-RamirezE]]BehaniM]]LeggiadroRJCommunity-associated methicillin-resistant staphylococcal infection in an inner city hospital pediatric inpatient population.South Med J2009102135-1389. Rajendran PM, Young D, Maurer T, et al. Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother 2007;51:4044–4048.RajendranPM]]YoungD]]MaurerT&etal;Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection.Antimicrob Agents Chemother2007514044-4048
